{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T12:59:37Z","timestamp":1780059577585,"version":"3.54.0"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>Toxic epidermal necrolysis (TEN) is a rare, life-threatening mucocutaneous disorder, and its occurrence in elderly patients with compromised immunity and multiple comorbidities poses significant challenges to nursing care and prognosis. This paper summarizes the ICU nursing experience of an 84-year-old female patient with TEN presumably induced by parecoxib injection. The patient presented with 55% body surface area (BSA) skin involvement, combined with bedridden status due to fracture and electrolyte disturbances, with an expected mortality rate of 30\u201350%. An individualized nursing plan was formulated through multidisciplinary collaboration. Clinically, skin wound care was the cornerstone of management, incorporating refined, stage-specific interventions during the blister exudation, crusting, and healing phases, with yellow light irradiation and epidermal growth factor applied throughout all phases to promote wound healing. Targeted nursing measures were applied to vulnerable mucous membranes, particularly the oral cavity, eyes, and perianal region, including occlusive therapy and fecal diversion using ostomy bags to reduce local irritation. A midline catheter was prioritized, and an innovative adhesive-free dressing fixation strategy was adopted to ensure the safety of intravenous access. Full-process protective isolation and strict aseptic techniques were implemented to strengthen infection prevention and control. Meanwhile, medication nursing for immunomodulation, anti-inflammatory therapy, and symptomatic supportive care was delivered in accordance with the S3 Guideline: Diagnosis and Treatment of Epidermal Necrolysis (Stevens\u2013Johnson Syndrome and Toxic Epidermal Necrolysis) developed by the German Dermatological Society (Deutsche Dermatologische Gesellschaft, DDG). Following 17\u202fdays of systematic nursing care, the patient\u2019s wounds achieved nearly complete epithelialization, with no new blisters or exudation observed. Infection markers were significantly reduced, and the patient was successfully transferred to a rehabilitation ward. Her recovery duration was shorter than the average for similar patients, and no severe ocular complications developed. This case demonstrates that a comprehensive nursing strategy incorporating staged wound care, multidimensional mucosal protection, individualized intravenous access management, and full-process infection control can effectively reduce complication risks, accelerate wound healing, and improve outcomes in elderly patients with severe TEN, providing a reference for clinical nursing practice in this vulnerable population.<\/jats:p>","DOI":"10.3389\/fmed.2026.1824922","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:21:08Z","timestamp":1776918068000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Nursing care of an elderly patient with toxic epidermal necrolysis: a case report"],"prefix":"10.3389","volume":"13","author":[{"given":"Danqiong","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Intensive Care Unit, Ningbo No. 6 Hospital","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengjiao","family":"Yuan","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Unit, Ningbo No. 6 Hospital","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ying","sequence":"additional","affiliation":[{"name":"Department of Nursing, Ningbo No. 6 Hospital","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s40257-024-00889-6","article-title":"Update on Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: diagnosis and management","volume":"25","author":"Shah","year":"2024","journal-title":"Am J Clin Dermatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.alit.2025.05.008","article-title":"Recent advances in the diagnosis and treatment of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"74","author":"Watanabe","year":"2025","journal-title":"Allergol Int"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/bjd\/ljae321","article-title":"Recent progress of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: diagnosis criteria, pathogenesis and therapy","volume":"192","author":"Hama","year":"2024","journal-title":"Br J Dermatol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"895","DOI":"10.3390\/medicina57090895","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a review of diagnosis and management","volume":"57","author":"Frantz","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jdin.2023.06.014","article-title":"Epidemiology of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in the United States and factors predictive of outcome","volume":"13","author":"Wasuwanich","year":"2023","journal-title":"JAAD Int"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1007\/s00403-025-04214-x","article-title":"Adalimumab combination with corticosteroid therapy for Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"317","author":"Liu","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1111\/ddg.15515","article-title":"S3 guideline: diagnosis and treatment of epidermal necrolysis (Stevens\u2013Johnson syndrome and toxic epidermal necrolysis)\u2014part 1: diagnosis, initial management, and immunomodulating systemic therapy","volume":"22","author":"Heuer","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1046\/j.1523-1747.2000.00061.x","article-title":"SCORTEN: a severity-of-illness score for toxic epidermal necrolysis","volume":"115","author":"Fouchard","year":"2000","journal-title":"J Invest Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"E138","DOI":"10.1097\/asw.0000000000000373","article-title":"Summary of the best evidence on skin-mucosal care in Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"38","author":"Lei","year":"2025","journal-title":"Adv Skin Wound Care"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"103282","DOI":"10.1016\/j.annder.2024.103282","article-title":"French national protocol for diagnosis and management of epidermal necrolysis in adults (Stevens\u2013Johnson syndrome and toxic epidermal necrolysis)","volume":"151","author":"Ingen-Housz-Oro","year":"2024","journal-title":"Ann Dermatol Venereol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.4037\/aacnacc2020634","article-title":"Stevens-Johnson syndrome and toxic epidermal necrolysis: a guide for nurses","volume":"31","author":"Hanson","year":"2020","journal-title":"AACN Adv Crit Care"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"101046","DOI":"10.1016\/j.waojou.2025.101046","article-title":"Latin American guidelines for the diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"18","author":"Murillo-Casas","year":"2025","journal-title":"World Allergy Organ J"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.jaad.2020.02.066","article-title":"Society of dermatology hospitalists supportive care guidelines for the management of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis in adults","volume":"82","author":"Seminario-Vidal","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/vision9030078","article-title":"Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a systematic review of ophthalmic management and treatment","volume":"9","author":"Sawires","year":"2025","journal-title":"Vision"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.35541\/cjd.20240354","article-title":"Clinical application of red, blue, and yellow light therapy in dermatology: an expert consensus statement","volume":"58","year":"2025","journal-title":"Chin J Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/bjd.19893","article-title":"Supportive care in the acute phase of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: an international, multidisciplinary Delphi-based consensus","volume":"185","author":"Br\u00fcggen","year":"2021","journal-title":"Br J Dermatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/ijp.ijp_485_23","article-title":"Drug-induced Stevens\u2013Johnson syndrome in post traumatic facial injury","volume":"56","author":"Samar","year":"2024","journal-title":"Indian J Pharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2040622319894469","DOI":"10.1177\/2040622319894469","article-title":"Multidisciplinary care in Stevens\u2013Johnson syndrome","volume":"11","author":"Shanbhag","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"ofad024","DOI":"10.1093\/ofid\/ofad024","article-title":"Comparing complication rates of midline catheter vs peripherally inserted central catheter: a systematic review and meta-analysis","volume":"10","author":"Urtecho","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1097\/nan.0000000000000532","article-title":"Infusion therapy standards of practice, 9th edition","volume":"47","author":"Nickel","year":"2024","journal-title":"J Infus Nurs"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.12968\/jowc.2025.0447","article-title":"In vitro performance of Biatain superabsorber and use in management of moderately-to-highly exuding wounds","volume":"35","author":"Zobel","year":"2026","journal-title":"J Wound Care"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/10783903241252810","article-title":"Stevens-Johnson syndrome, toxic epidermal necrolysis: macules, papules, and bullae","volume":"30","author":"Vossos","year":"2024","journal-title":"J Am Psychiatr Nurses Assoc"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1460579","DOI":"10.3389\/fped.2024.1460579","article-title":"Case report: multi-targeted therapy in the treatment of severe toxic epidermal necrolysis","volume":"12","author":"Kwong","year":"2024","journal-title":"Front Pediatr"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"376","DOI":"10.35541\/cjd.20201177","article-title":"Expert consensus on the diagnosis and treatment of Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis","volume":"54","year":"2021","journal-title":"Chin J Dermatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1824922\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T04:21:09Z","timestamp":1776918069000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1824922\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":25,"alternative-id":["10.3389\/fmed.2026.1824922"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1824922","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"article-number":"1824922"}}